Xtant receives $10.7M from Companion Spine; repays note, adjusts purchase price; total proceeds $21.4M

Xtant Medical Holdings, Inc.

Received $10.7M on Feb 27, 2026 from Companion Spine: full repayment of $8.2M note plus accrued interest and working capital adjustments.
Total aggregate purchase price for Coflex/CoFix asset sale and Paradigm divestiture now $21.4M.
$2.8M of proceeds used to prepay portion of MidCap term loan; remaining principal $11.1M.
Original $19.2M purchase price included $8.2M note maturing Jan 31, 2026, now settled.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.